• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Linc

74.80 SEK+0.13 %24/7 17:29
Less than 1K followers

LINC

NASDAQ Stockholm

Investment

Financials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.13 %
+10.49 %
+7.94 %
+19.11 %
+7.32 %
-5.67 %
+17.24 %
-26.49 %
-12.00 %

Linc is a company that invests in product-oriented companies within the Nordic Life Science industry. The company invests in and develops primarily small and medium-sized life science companies within Medical Technology and Pharmaceuticals. The investments are made in both private and public companies and in research and operating companies. Linc was founded in 1991 and is headquartered in Stockholm.

Read more
Market cap
4.33B SEK
Turnover
1.36M SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
All
Press releases
ShowingAll content types

Financial calendar
22/10
2026

Interim report Q3'26

21/1
2027

Annual report '26

Regulatory press release2026-07-24 18:00

Återköp av aktier i Linc 16 juli 2026 – 24 juli 2026

Linc
Regulatory press release2026-07-16 07:00

Delårsrapport Linc AB (publ) 1 januari – 30 juni 2026

Linc
Regulatory press release2026-06-22 17:30

Återköp av aktier i Linc 11 juni 2026 – 22 juni 2026

Linc

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-10 18:00

Återköp av aktier i Linc 1 juni 2026 – 10 juni 2026

Linc
Press release2026-06-03 07:00

Substansvärde 2026 05 31

Linc
Regulatory press release2026-05-21 23:30

Linc beslutar om aktieåterköpsprogram

Linc
Regulatory press release2026-05-13 17:30

Stämmokommuniké årsstämma 13 maj 2026

Linc
Press release2026-05-05 07:00

Substansvärde 2026 04 30

Linc
Regulatory press release2026-04-23 07:00

Delårsrapport Linc AB (publ) 1 januari – 31 mars 2026

Linc
Regulatory press release2026-04-10 07:00

Kallelse Årsstämma i Linc AB den 13 maj 2026

Linc
Regulatory press release2026-03-19 07:00

Årsredovisningen 2025 offentliggjord

Linc
Press release2026-03-03 07:00

Substansvärde 2026 02 28

Linc
Press release2026-02-03 07:00

Substansvärde 2026 01 31

Linc
Regulatory press release2026-01-22 07:00

Bokslutskommuniké 2025 Linc AB (publ)

Linc
Press release2025-12-02 07:00

Substansvärde 2025 11 30

Linc
Press release2025-11-04 07:00

Substansvärde 2025 10 31

Linc
Press release2025-10-24 10:14

Investor Studios: Lincs VD Karl Tobieson kommenterar rapporten i Market Update

Linc
Regulatory press release2025-10-23 07:00

Delårsrapport Linc AB (publ) 1 januari – 30 september 2025

Linc
Regulatory press release2025-10-10 13:30

Linc AB:s valberedning inför årsstämma 2026

Linc
Press release2025-09-02 07:00

Substansvärde 2025 08 31

Linc